“A promising new treatment for glioblastoma has been shown to eliminate the tumour and prevent recurrence in animal studies, achieving what researchers “thought impossible”.
Trogenix has announced the publication of its breakthrough pre-clinical data in Nature, reporting complete tumour eradication in 83% of treated cases and durable protection in a brain cancer model that closely mimics human glioblastoma.” Read article here.
A novel treatment for glioblastoma, consisting of a combination of an oncolytic virus, engineered to selectively infect and kill cancer cells, and type of a targeted immunotherapy called immune checkpoint inhibition, is showing promise, prolonging patient survival. Read the article from the University of Toronto here.
The Mayo Clinic Comprehensive Cancer Center and Columbia University have been awarded a five-year, $10.6 million grant from the National Cancer Institute (NCI) to advance glioblastoma research. For details, read this article.
This is interesting: “Among glioblastoma patients, women may derive more benefit from immunotherapy than men, research suggests.”
See full article here.
“Their study is the first to demonstrate an intravenous medication that can cross the blood-brain barrier. The discovery may one day lead to new clinical therapies for treating glioblastoma, and could lead to further therapies adopting their method for other “undruggable” tumors.”
Read more about how nanomedicine could be a potential treatment/cure for GBMs.
This study [PDF] reviews traditional Chinese medicine and how it can help with the treatment of GBMs.
A new study was released looking at focused ultrasound to help treat GBMs. To read the article, click here.
This is the orignial article citation:
Sheehan et al. (2020). Investigation of the tumoricidal effects of sonodynamic therapy in malignant glioblastoma brain tumors. Journal of Neuro-Oncology. DOI: https://doi.org/10.1007/s11060-020-03504-w
Check out the new series on Netflix called Lenox Hill. The series follows the incredible neurosurgeons at Lenox Hill Hospital as they help patients with GBMs.
A 2016 study from Clinical Cancer Research suggests that a low carb, high fat diet can have similar anti-tumor, metabolic effects as the ketogenic diet (KD). However, this diet is less restrictive and more palatable than the KD, so it could offer an alternative for glioblastoma patients.
See the full article online at Clinical Cancer Research.
Here is a short clip from CTV News on GBMs, spreading awareness of GBMs, and speaking briefly about Paul Dewar’s experience with the illness.